University of Vermont College of Medicine
1 South Prospect Street
Burlington, Vermont 05401
802-656-8990 http://www.med.uvm.edu/clinicaltrials clinicaltrials@uvm.edu

Use our guide to learn which trials are right for you!

The integrated academic health center at the University of Vermont College of Medicine and Fletcher Allen Health Care, its teaching hospital, has contributed to medical research for nearly two centuries. Recently, our academic health center has dramatically increased its clinical research productivity by using innovative methods of recruitment and state-of-the-art technology, evolving into one of the top research centers in the region. In order to meet the needs of our industry partners, our clinical research enterprise is structured with a focus on integrity, promptness, and flexibility, enhanced by the extensive resources of the institution, including the Vermont Children's Hospital, the General Clinical Research Center, the Vermont Cancer Center, the Vermont Lung Center, a dedicated Research Pharmacy, and many other research services. In addition, our outstanding relationship with private practices in the region strongly enhances the recruitment activities of clinical trials.

As one of the first medical schools founded in the United States, groundbreaking medical research has been a hallmark of the institution for decades. Among the many innovations developed here include a breakthrough new medicine for life-threatening sepsis pioneered by our researchers, and development of new treatments for depression in senior citizens. We are one of only 20 states in the nation to have both a National Institutes of Health-funded General Clinical Research Center, a National Cancer Institute funded Comprehensive Cancer Center. Our long history of excellence in research, teaching, and patient care, coupled with our dedication to attracting quality research projects, ensures that research conducted here will be efficient, effective and completed on time. We are an investigational site with nearly 200 years of clinical research experience in conducting Phase I - IV trials. In addition to study coordination, our staff can provide consulting in protocol development and design, manuscript preparation, and medical writing.

Some of our specialties include:

  • Addiction Research and Education
  • Asthma, Allergy and Immunology
  • Cardiology
  • Critical Care Medicine
  • Dermatology
  • Endocrinology, Diabetes and Metabolism
  • Emergency Medicine
  • Family Medicine
  • Food and Nutrition
  • Genetics
  • Gastroenterology and Hepatology
  • Geriatrics
  • Hematology
  • Infectious Diseases
  • Imaging Sciences
  • Medical Genetics
  • Medical Microbiology and Immunology
  • Medical Physics
  • Molecular and Cellular Pharmacology
  • Nephrology and Renal Disorders
  • Neurology and Neuroscience
  • Obstetrics and Gynecology
  • Oncology
  • Ophthalmology and Visual Science
  • Organ Transplantation
  • Orthopedics and Rehabilitation
  • Osteoporosis
  • Pathology
  • Pediatrics (all sub-specialties)
  • Pharmacology
  • Physiology
  • Preventive Medicine
  • Psychiatry
  • Pulmonary Medicine - Respiratory Care
  • Radiology
  • Rehabilitation Medicine
  • Rheumatology and Clinical Immunology
  • Sports Medicine
  • Surgery (all sub-specialties)
  • Tobacco Research and Intervention
  • Urology
  • Vascular Disease

Investigator and Staff:

A private, publicly supported integrated health care system, our organization features a medical staff of 700 physicians and a nursing staff of over 1,200 registered nurses. Our clinical research staff has coordinated hundreds of studies for pharmaceutical and biotechnology industry sponsors, foundations, and the National Institutes of Health. We deliver high-quality, accurate results by adhering closely to research protocols. Our experienced study coordinating, recruiting, and research staff is readily available to quickly address questions and to meet with monitors.

In this section of the site we invite you to learn more about the University of Vermont College of Medicine and Fletcher Allen Health Care - from our mission and history to our research departments and the communities we serve. Serving a population of more than one million in Vermont, northern New York, and throughout New England, we have an established network to provide us with rapid referrals of new patients so that we may quickly reach your enrollment goals.


Cardiology/Vascular Diseases
Dermatology/Plastic Surgery
Endocrinology
Gastroenterology
Hematology
Immunology/Infectious Diseases
Musculoskeletal
Nephrology/Urology
Neurology
Obstetrics/Gynecology
Oncology
Ophthalmology
Otolaryngology
Pediatrics/Neonatology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology
Trauma/Emergency Medicine

The University of Vermont College of Medicine, in alliance with Fletcher Allen Health Care, is a premier academic medical center in the northeast and one of 125 in the country. Our mission is to improve the health in the communities we serve through compassionate patient care, education and research. The outstanding caregivers at Fletcher Allen - including nationally-renown physicians, specialized nurses and allied health professionals - are committed to providing our patients with only the highest-quality care. The academic medical center takes an active role in participating in finding cures to today's illnesses through medical research and training tomorrow's health professionals. The 562-bed includes more than 40 patient care sites and 100 outreach clinics.


Kimberly Luebbers, MSHS, RN, BSN, OCN ®
Director Office of Clinical Trials Research
University of Vermont College of Medicine
Office of Clinical Trials Research
UHC Campus, Arnold 3437
1 South Prospect Street
Burlington, VT 05401
USA
802-656-8990
802-656-4074 (fax)
clinicaltrials@uvm.edu
www.med.uvm.edu/clinicaltrials


We've found
54 trials
at this facility
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling, Phase III
Updated: 1/26/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
International Guillain-Barré Syndrome Outcome Study
Status: Enrolling
Updated: 3/2/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Status: Enrolling, Phase III
Updated: 9/18/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases, Other Clinical Trial
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Status: Enrolling, Phase II
Updated: 2/22/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Dermatomyositis Clinical Trial
Trial of IMO-8400 in Adult Patients With Dermatomyositis
Status: Enrolling, Phase II
Updated: 3/7/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Status: Enrolling, Phase III
Updated: 9/3/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Severe Sepsis Clinical Trial
Zinc Therapy in Critical Illness
Status: Enrolling, Phase I
Updated: 7/23/2014
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Status: Enrolling, Phase III
Updated: 9/9/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Lymphoma Clinical Trial
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 8/25/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Status: Enrolling, Phase II, III
Updated: 6/25/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 9/30/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Status: Enrolling, Phase II
Updated: 12/11/2015
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Status: Enrolling, Phase II
Updated: 2/9/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
Confirmatory Study of Eteplirsen in DMD Patients
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Recurrent Mantle Cell Lymphoma Clinical Trial
Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Untreated Adult Acute Myeloid Leukemia Clinical Trial
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 2/1/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Status: Enrolling, Phase II
Updated: 3/7/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 2/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 3/14/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 3/14/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Lenalidomide in Treating Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling, Phase III
Updated: 1/29/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Musculoskeletal, Oncology Clinical Trial
S1202: Duloxetine Hydrochloride to Treat Muscle, Bone, and Joint Pain in Pts W/Early-Stage Breast Cancer Receiving Hormone Therapy
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
Status: Enrolling, Phase II
Updated: 3/30/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 1/29/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 2/2/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Status: Enrolling, Phase III
Updated: 3/11/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Status: Enrolling, Phase II
Updated: 3/14/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Burlington, VT
Click here to add this to my saved trials